维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Altman JK"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia显示文摘	Tallman MS Abutalib SA Altman JK	2007	Semin Thromb Hemost2007，33，：	1
2	Targeting AMPK in the treatment of malignancies显示文摘	Vakana E Altman JK Platanias LC	2012	J Cell Bioehem2012，113，2：	1
3	Administration of ATRA to newly diagnosed patients with acute premyeloeytie leukemia is de-layed contributing to early hemorrhagic death 显示文摘	Altman JK R ademaker A Cull E	2013	Leuk Res2013，37，9：	1
4	Regulatory effects of mam-malian target of rapamycin - mediated signals in the generation of arsenic trioxide responses显示文摘	Altman JK Yoon P Katsoulidis E	2008	Biol Chem2008，283，4：	1
5	Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses 显示文摘	Altman JK Yoon P Katsoulidis E	2005	J Biol Chem2005，283，4：	1
6	Regnlatory effects of mam- malian target of rapamycin - mediated signals in the generation of arsenic trioxide responses 显示文摘	Altman JK Yoon P Katsoulidis E	2008	Biol Chem2008，283，4：	1
7	Dual mTORC2/mTORC 1targeting results in potent suppressive effects on acute myeloidleukemia (AML) progenitors 显示文摘	Altman JK Sassano A Kaur S	2011	Clin Cancer Res2011，17，13：	1
8	How I treat acute promyelocytic leukemia显示文摘	Tallman MS Altman JK	2009	Blood2009，114，25：	1
9	How I treat acute promyelocytic leukemia 显示文摘	Tallman MS Altman JK	2009	Blood2009，114，25：	1
10	Targeting AMPK in the treat- ment of malignancies 显示文摘	Vakana E Altman JK Platanias LC	2012	J Cell Biochem2012，113，2：	1
11	Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide显示文摘	Goussetis DJ Altman JK Glaser H	2010	Biol Chem2010，285，29：	1
12	Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses 显示文摘	Altman JK Yoon P Katsoulidis E	2008	J Biol Chem2008，283，：	1
13	AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a phase I study in patients with IDH2 mutation positive advanced hematologic malignancies 显示文摘	Stein EM Altman JK Collins R	2014	Blood ( ASH annual meeting Abstracts )2014，124，21：	1
14	Contemporary treatment of APL显示文摘	Cull EH Altman JK	2014	Curr Hematol Malig Rep2014，9，：	1
15	New strategies for relapsed acute myeloid leukemia:fertile ground for translational research显示文摘	Dinner SN Giles FJ Altman JK	2014	Curr Opin Hematol2014，21，2：	1
16	The double hazard of tbrombophilia and bleeding in acute promyelocytic leukemia显示文摘	Tallman MS Abutalib SA Altman JK		0，，04：	1
17	How I treat acute promyeloeytie leukemia显示文摘	Tallman MS Altman JK	2009	Blood2009，114，25：	1
18	Protein kinaseR as mediator of the effects of interferon ( IFN ) y andtumor necrosisfactor ( TNF) a on normal and dysplasticheraatopoiesis 显示文摘	Sharma B Altman JK Goussetis DJ	2011	J Biol Chem2011，286，31：	1
19	Exploiting the mammalian target of rapamycin pathway in hematologic malignancies显示文摘	Altman JK Platanias LC	2008	Current Opin Hematol2008，15，2：	1
20	Development of a risk re- duction intervention to reduce bacterial and viral infections for in- jection drug users 显示文摘	Phillips KT Altman JK Corsi KF	2013	Subst Use Misuse2013，48，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示